FDA Revises Recommendations For Rotavirus Vaccines

Links shared publicly online about this topic.

  • 1,162
    total visits

FDA Revises Recommendations For Rotavirus Vaccines

medicalnewstoday.com

The U.S. Food and Drug Administration revised its recommendations for rotavirus vaccines for the prevention of the disease in infants and has determined that it is appropriate for clinicians and h

View full resource at medicalnewstoday.com

Tags: Vaccination, Disease and Condition, Drug, Children's Health, FDA, Vaccine

  • Share

Most Recently Shared on May 17, 2010 at 5:56 pm By:

Disease_Infect Infectious Disease

FDA Revises Recommendations For Rotavirus Vaccines: The U.S. Food and Drug Administration revised its recommendati... http://mnt.to/f/3CHP

2 years ago...

Also Shared By:

MNT Vaccines MNT Vaccines

MNT Infect Diseases MNT Infect Diseases

MNT Drug Approvals MNT Drug Approvals

FDA warns of bowel obstruction risk linked to Rotarix - Related Stories - AAP SmartBrief

smartbrief.com — “The FDA warned that Rotarix, a rotavirus vaccine by GlaxoSmithKline, might cause an increased risk of intussusception. The warning is based on preliminary data from a Mexican study involving infants. "Although the results are preliminary and will require further evaluation, FDA approved revised labeView full resource at smartbrief.com

  • View Related
  • Share

Most Recently Shared on September 23, 2010 at 7:24 pm By:

songMD Clara Song Physician, Doctor, and Pediatrician

FDA warns of bowel obstruction risk linked to Rotarix http://sbne.ws/r/5IFS

2 years ago...

U.S. healthcare practitioners can resume use of Rotarix, says FDA

news-medical.net — “GlaxoSmithKline announced that the Food and Drug Administration has determined that U.S. healthcare practitioners can resume the use of Rotarix (Rotavirus Vaccine, Live, Oral), effective immediately. This action supersedes the FDA's recommendation from March 22, 2010 and reflects the agency's assessment that the presence of porcine circovirus type 1 in the vaccine poses no safety risk.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 15, 2010 at 4:47 am By:

NewsMedical News-Medical.Net Health News

U.S. healthcare practitioners can resume use of Rotarix, says FDA: GlaxoSmithKline announced that the Food and Dru... http://bit.ly/avU0sC

2 years ago...

FDA: Rotavirus Vaccines Safe Despite Pig Virus

children.webmd.com — “Both rotavirus vaccines given to U.S. infants carry tiny amounts of pig virus or pig virus DNA. But FDA recommends continued use of the vaccines due to their strong safety record.View full resource at children.webmd.com

  • View Related
  • Share

Most Recently Shared on May 14, 2010 at 9:20 pm By:

HeartsHealth Heart Health Health News

webMD: FDA: Rotavirus Vaccines Safe Despite Pig Virus http://bit.ly/brRkTt Full http://bit.ly/chFkXw

2 years ago...

FDA recommends resumption of rotavirus vaccine use - MPR

empr.com — “The FDA has revised its recommendations on the suspension of rotavirus vaccine use and has determined that it is appropriate for healthcare providers to resume the use of Rotarix (live, attenuated human G1P[8] rotavirus vaccine, from GlaxoSmithKline) and RotaTeq (pentavalent, live rotavirus vaccine, from Merck).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on May 14, 2010 at 8:49 pm By:

eMPR MPR Medical Publisher

FDA recommends resumption of rotavirus vaccine use: The FDA has revised its recommendations on the suspension of r... http://bit.ly/aOikIE

2 years ago...

FDA recommends resumption of rotavirus vaccine use - ONA

oncologynurseadvisor.com — “The FDA has revised its recommendations on the suspension of rotavirus vaccine use and has determined that it is appropriate for healthcare providers to resume the use of Rotarix (live, attenuated human G1P[8] rotavirus vaccine, from GlaxoSmithKline) and RotaTeq (pentavalent, live rotavirus vaccine, from Merck).View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on May 14, 2010 at 8:47 pm By:

FDA recommends resumption of rotavirus vaccine use - MPR

empr.com — “The FDA has revised its recommendations on the suspension of rotavirus vaccine use and has determined that it is appropriate for healthcare providers to resume the use of Rotarix (live, attenuated human G1P[8] rotavirus vaccine, from GlaxoSmithKline) and RotaTeq (pentavalent, live rotavirus vaccine, from Merck).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on May 14, 2010 at 8:22 pm By:

eMPR MPR Medical Publisher

MPR News: FDA recommends resumption of rotavirus vaccine use: The FDA has revised its recommendations on the suspe... http://bit.ly/bb6pkJ

2 years ago...

Update on Recommendations for the Use of Rotavirus Vaccines

fda.gov — “Update on Recommendations for the Use of Rotavirus VaccinesView full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on May 14, 2010 at 6:46 pm By:

marynmck Maryn McKenna Health Communicator

FDA clears rotavirus vaccines for use despite presence fragments porcine circovirus; benefit clear, risk "theoretical" http://bit.ly/drC1DE

2 years ago...

MHA News Now: Recommendation to Temporarily Suspend Usage of GlaxoSmithKline Rotarix (Rotavirus) Vaccine

mhanewsnow.typepad.com — “The U.S. Food and Drug Administration (FDA) has learned that DNA from porcine circovirus type 1 (PCV1), a virus not known to cause disease in humans, is present in the Rotarix vaccine. All available evidence indicates that there has been...View full resource at mhanewsnow.typepad.com

  • View Related
  • Share

Most Recently Shared on March 24, 2010 at 11:00 pm By:

MHA MS Hospital Assoc. Health Organization

Recommendation to Temporarily Suspend Usage of GlaxoSmithKline Rotarix (Rotavirus) Vaccine http://bit.ly/9zWA02

2 years ago...

FDA Suspends GlaxoSmithKline's Rotarix Vaccine - WSJ.com

online.wsj.com — “The FDA recommended that doctors temporarily stop using GlaxoSmithKline's Rotarix vaccine after an extraneous virus was found in the product.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on March 23, 2010 at 4:21 am By:

FDA recommends temporary halt in use of GlaxoSmithKline's Rotarix vaccine for infants - WSJ.com

online.wsj.com — “Approved for use in the U.S. in 2008, Rotarix is typically given to babies at two and four months of age to help protect against rotavirusView full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on March 22, 2010 at 10:35 pm By:

Advertisement